Savant Capital’s DexCom DXCM Stock Holding History

Savant Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Hold	0	–	-$2.52M	–	606
2022 Q3	–	Hold	0	–	–	–	126
2022 Q2	–	Sell	-1,200	Closed	-$110K	–	537
2022 Q1	$153K	Hold	1,200	–	–	0.01%	554
2021 Q4	$161K	Hold	1,200	–	–	0.01%	547
2021 Q3	$164K	Hold	1,200	–	–	0.01%	507
2021 Q2	$128K	Hold	1,200	–	–	0.01%	488
2021 Q1	$108K	Hold	1,200	–	–	0.01%	461
2020 Q4	$111K	Buy	+1,200	New	+$107K	0.01%	429

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Savant Capital's DXCM Position: Q2 2026 in Review

Savant Capital reduced its DexCom (DXCM) stake by 1.5% in Q2 2026, selling an estimated $15.2K and leaving 15,175 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #876.

Savant Capital first reported a position in DXCM in Q2 2013 and has held it in 51 quarters since. The position peaked at $15.9M in Q3 2021. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Savant Capital held 15,175 shares of DexCom worth $1.03M as of Q2 2026.
Savant Capital sold 228 DexCom shares in Q2 2026, an estimated $15.2K.
DexCom made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #876 holding.
Savant Capital first reported a position in DexCom in Q2 2013 and has held it in 51 quarters since.
Savant Capital's DexCom position peaked at $15.9M in Q3 2021.
976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.